Six variables. Check them every quarter.
Any one of #1, #2, #6 going hard against the thesis is potentially fatal in the relevant timeframe. #3, #4, #5 are degrade-but-survive variables.
Things-must-go-right scorecard
| # | Must-go-right | Monitoring catalyst | Frequency | Severity | Status (today) |
|---|---|---|---|---|---|
| 01 | Coinbase Aug 2026 renewal lands at NO WORSE than current 50/50 split | Aug 2026 contract disclosure (8-K) | single event | FATAL | pending |
| 02 | GENIUS yield-prohibition stays intact — no CLARITY loophole closure that backfires AND no Path C amendment | CLARITY language (May 2026); subsequent Congresses | quarterly | FATAL | monitor |
| 03 | USDC float compounds at minimum 20% CAGR (≥$130B by end-2027, ≥$160B by end-2028) | Quarterly earnings · DefiLlama / Coin Metrics weekly | monthly | degrade | on track (+28% YoY) |
| 04 | Bank consortium / tokenised-deposit moves DON'T capture >25% of US institutional float by 2028 | JPMD/Kinexys volume · WFUSD launch · consortium product disclosures | quarterly | degrade | on track |
| 05 | ARC mainnet ships and shows real institutional usage, OR CPN scales from $5B annualised to $50B+ | ARC mainnet 2H 2026 · CPN volume in earnings | quarterly | degrade | CPN $5.7B annualised |
| 06 | Rate path: Fed funds doesn't drop below 2.0% before float scales to ~$150B+ | FOMC dot plot updates · SOFR | monthly | FATAL | SOFR 3.5% · dot plot 3.0-3.25% terminal |
The thesis is hostage to three single-point variables
Items #1, #2, #6 are each individually capable of breaking the thesis in their relevant timeframe. That's why the sizing is small until the first of them resolves.
Items #3, #4, #5 are degrade-but-survive variables. They affect the magnitude of the upside but not the existence of it.
What would change the verdict, both directions
A clean Aug 2026 Coinbase renewal — defined as same-or-better economic terms with no expansion of "on-platform" definitions, ideally with directional pressure on Coinbase's residual share (e.g., a step-down to 45% in years 2-3).
Combined with Fed staying at ≥3% and one quarter showing CPN annualised run-rate >$30B (vs today's ~$5B), the asymmetry ratio shifts from ~1.5:1 to ~3:1 even at $160-180 prices.
At that point, the thesis becomes a real medium-conviction compounder and 4-5% sizing is warranted.
Either kill criterion #1 or #2; OR a confluence of:
- a. BUIDL/BENJI tokenised-MMF AUM crosses $20B (today $9B) signalling institutional treasury migration.
- b. Credible bank consortium product launches with named pilot enterprise customers totalling >$10B committed flow.
- c. Q2 or Q3 2026 reserve return rate compresses below 3.0% on Fed cuts.
The combination implies the bull legs are failing in sequence and the next leg (Coinbase) is uncomfortably close to negative.
Where the analysis is thinnest
Coinbase contract details
Renewal triggers, escape clauses, "on-platform" definitions are opaque. Close read of S-1 collaboration agreement filing + Coinbase 10-Q would help.
ARC tokenomics
Implied $750M paper value at 25% retention. Nobody has modelled mid-case ARC contribution in 2027-28 P&L — could be 10%+ of market cap if it works.
Float decomposition
CEX vs DeFi vs payments vs treasury. Bull case (payments rail) vs bear case (still crypto-cyclical) hinges on whether non-crypto buckets are 25% or 10% of float.
Tokenised-deposit trajectory
JPMD, WFUSD, EWS consortium. Reading JPMorgan Kinexys' Q1 2026 disclosures + tracking consortium timeline would reveal whether this is 2026-27 or 2028-29 threat.